Perspectives for the treatment of brucellosis in the 21st century: the Ioannina recommendations. (Q33312505)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18162038%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

title

Perspectives for the treatment of brucellosis in the 21st century: the Ioannina recommendations (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18162038%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

0 references

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18162038%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

Georgios Pappas

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18162038%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

7

Ziad A Memish

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18162038%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

6

Matthew E Falagas

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18162038%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

1

Javier Ariza

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18162038%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

author name string

Mile Bosilkovski

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18162038%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

Juan D Colmenero

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18162038%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

Michael J Corbel

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18162038%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

Mohammad Reza Hasanjani Roushan

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18162038%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

Ethan Rubinstein

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18162038%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

Nikolaos V Sipsas

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18162038%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

Javier Solera

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18162038%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

Edward J Young

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18162038%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

International Society of Chemotherapy

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18162038%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

Institute of Continuing Medical Education of Ioannina

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18162038%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

language of work or name

English

0 references

publication date

1 December 2007

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18162038%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18162038%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

volume

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18162038%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

page(s)

e317

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18162038%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

issue

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18162038%20AND%20SRC:MED&resulttype=core&format=json

Creative Commons CC0 License

31 December 2019

copyright license

start time

27 December 2007

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted, dedicated to the public domain by copyright holder

0 references

cites work

Doxycycline-rifampicin: physicians' inferior choice in brucellosis or how convenience reigns over science.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2222927

Intracellular killing of Brucella melitensis in human macrophages with microsphere-encapsulated gentamicin

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2222927

Efficacy of gentamicin plus doxycycline versus streptomycin plus doxycycline in the treatment of brucellosis in humans.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2222927

The new global map of human brucellosis.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2222927

Quinolones for treatment of human brucellosis: critical review of the evidence from microbiological and clinical studies

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2222927

Tigecycline: a novel glycylcycline

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2222927

Genetic bases of the rifampin resistance phenotype in Brucella spp.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2222927

Treatment of brucella spondylitis: lessons from an impossible meta-analysis and initial report of efficacy of a fluoroquinolone-containing regimen.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2222927

Brucellosis and international travel

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2222927

Efficacy of some new antibiotics in treating experimental brucellosis

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2222927

Epididymoorchitis due to Brucella mellitensis: a retrospective study of 59 patients

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2222927

Azithromycin and gentamicin therapy for the treatment of humans with brucellosis

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2222927

Brucella bacteraemia: clinical and laboratory observations in 160 patients

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2222927

Brucellar spondylitis: review of 35 cases and literature survey

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2222927

Increasing resistance of Brucellae to co-trimoxazole.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2222927

Multivariate model for predicting relapse in human brucellosis

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2222927

21 June 2018

Brucellosis: an overview

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2222927

Recognition and optimum treatment of brucellosis

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2222927

Treatment of human brucellosis with doxycycline and gentamicin

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2222927

Once-daily aminoglycoside dosing in immunocompetent adults: a meta-analysis

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2222927

An overview of human brucellosis

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2222927

Possible implications of doxycycline-rifampin interaction for treatment of brucellosis

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2222927

A comparative study of therapeutic agents used for treatment of acute brucellosis.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2222927

Brucellar spondylitis: a detailed analysis based on current findings.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2222927

Brucella arthritis among Iraqi patients

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2222927

The Nature of Human Brucellosis in Kuwait: Study of 379 Cases

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2222927

Clinical pharmacokinetics of doxycycline and minocycline

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2222927

Human brucellosis in Kuwait: a prospective study of 400 cases

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2222927

Skeletal brucellosis in Iraqi patients

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2222927

Modern chemotherapy for brucellosis in humans

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2222927

Multicenter prospective study of treatment of Brucella melitensis brucellosis with doxycycline for 6 weeks plus streptomycin for 2 weeks

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2222927

Osteoarticular complications of brucellosis

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2222927

Treatment of human brucellosis with doxycycline plus rifampin or doxycycline plus streptomycin. A randomized, double-blind study

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2222927

Use of ciprofloxacin in the treatment of brucellosis

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2222927

Failure of ceftriaxone in the treatment of acute brucellosis

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2222927

The action of trimethoprim and rifampicin in combination against Gram-negative rods resistant to gentamicin

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2222927

Comparison of the efficacy of two months of treatment with co-trimoxazole plus doxycycline vs. co-trimoxazole plus rifampin in brucellosis

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2222927

Brucella Endocarditis: Clinical, Diagnostic, and Therapeutic Approach

31 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2222927

Treatment of human brucellosis with rifampin plus minocycline

31 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2222927

Progressive rise of Mycobacterium tuberculosis resistance to rifampicin and streptomycin in Riyadh, Saudi Arabia

31 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2222927

Brucellosis in pregnant women

31 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2222927

Open, randomized therapeutic trial of six antimicrobial regimens in the treatment of human brucellosis.

31 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2222927

Interactions of rifampin and trimethoprim in vitro.

31 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2222927

Drug interaction between rifampicin, isoniazid and cotrimoxazole in rabbits

31 October 2018

1 reference

12 December 2020

[Brucellosis in the 21st Century]

1 reference

12 December 2020

[Evaluation of the treatment of human brucellosis]

1 reference

12 December 2020

Comparative trial of co-trimoxazole versus tetracycline-streptomycin in treating human brucellosis

1 reference

12 December 2020

[Treatment of osteoarticular brucellosis with trimethoprim-sulfamethoxazole. Evaluation of 18 cases]

1 reference

12 December 2020

Quinolones for brucellosis: treating old diseases with new drugs

1 reference

12 December 2020

Health literacy in the field of infectious diseases: the paradigm of brucellosis

1 reference

12 December 2020

Joint FAO/WHO expert committee on brucellosis

1 reference

12 December 2020

[Effects of rifampicin on the pharmacokinetics of doxycycline]

1 reference

12 December 2020

Comparative trial of doxycycline plus streptomycin versus doxycycline plus rifampin for the therapy of human brucellosis

1 reference

12 December 2020

Diagnosis and treatment of 106 cases of human brucellosis

1 reference

12 December 2020

[Meta-analysis of the efficacy of the combination of +rifampicin and doxycycline in the treatment of human brucellosis]

1 reference

12 December 2020

Characteristics of and risk factors for relapse of brucellosis in humans

1 reference

12 December 2020

The protection of intracellular brucella against streptomycin alone and in combination with other antibiotics

1 reference

12 December 2020

Antibiotic treatment of acute brucellosis caused by Brucella melitensis

1 reference

12 December 2020

A randomized, double-blind study to assess the optimal duration of doxycycline treatment for human brucellosis

1 reference

12 December 2020

10.1371/JOURNAL.PMED.0040317

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18162038%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18162038%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

1 reference